Sue Stephens

4.6k total citations · 1 hit paper
36 papers, 3.4k citations indexed

About

Sue Stephens is a scholar working on Immunology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sue Stephens has authored 36 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 9 papers in Epidemiology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sue Stephens's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Inflammatory Bowel Disease (7 papers) and Immune Response and Inflammation (6 papers). Sue Stephens is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Inflammatory Bowel Disease (7 papers) and Immune Response and Inflammation (6 papers). Sue Stephens collaborates with scholars based in United Kingdom, United States and Germany. Sue Stephens's co-authors include Christian Braegger, Thomas T. MacDonald, Stephen J. Nicholls, Simon Murch, Roly Foulkes, Andrew Nesbitt, Niti Goel, Derek Brown, Tim Bourne and Marianne Bergin and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Blood.

In The Last Decade

Sue Stephens

36 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

1992 578 citations Christian Braegger, Stephen J. Nicholls et al. The Lancet profile →

Peers

Countries citing papers authored by Sue Stephens

Since Specialization

Citations

This map shows the geographic impact of Sue Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Stephens more than expected).

Fields of papers citing papers by Sue Stephens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Stephens. The network helps show where Sue Stephens may publish in the future.

Co-authorship network of co-authors of Sue Stephens

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Stephens. A scholar is included among the top collaborators of Sue Stephens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Stephens. Sue Stephens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease 2015 ·BMJ Open ·Sue Stephens, Marc Botteman, M. Cifaldi, Ben A. van Hout	10
2	The Use of Surrogate Antibodies to Evaluate the Developmental and Reproductive Toxicity Potential of an Anti-TNFα PEGylated Fab′ Monoclonal Antibody 2011 ·Toxicological Sciences ·Ian Wakefield, Sue Stephens, Roly Foulkes, Andrew Nesbitt, Tim Bourne	24
3	Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents 2007 ·Inflammatory Bowel Diseases ·Andrew Nesbitt, Gianluca Fossati, Marianne Bergin, Paul E. Stephens, Sue Stephens, Roly Foulkes, Derek Brown, Martyn K. Robinson, Tim Bourne	372
4	The effect of tuberculin testing on the development of cell-mediated immune responses during Mycobacterium bovis infection 2006 ·Veterinary Immunology and Immunopathology ·Michelle Thom, Jayne C. Hope, Martin McAulay, Bernardo Villarreal‐Ramos, Tracey J. Coffey, Sue Stephens, H. M. Vordermeier, Chris Howard	34
5	Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22 2004 ·Cancer Immunology Immunotherapy ·John F. DiJoseph, Andrew G. Popplewell, Simon Tickle, Heather M. Ladyman, Alastair D. G. Lawson, Arthur Kunz, Kiran Khandke, Douglas Armellino, Erwin R. Boghaert, Philip R. Hamann, K Zinkewich-Péotti, Sue Stephens, Neil Weir, Nitin K. Damle	55
6	Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community 1998 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·William McGuire, Umberto D’Alessandro, Sue Stephens, B.O. Olaleye, P. Langerock, Brian Greenwood, Dominic Kwiatkowski	23
7	The in vivo and in vitro characterisation of an engineered human antibody to E-selectin 1997 ·Immunotechnology ·Raymond J. Owens, (unknown), Ramaswamy Ganesh, Andrew Nesbitt, David C. Brown, (unknown), Sue Stephens, L Chaplin, Melpo Christofidou‐Solomidou, Sophia M. Blake, D. Howat, Wim A. Buurman, Steven Μ. Albelda, M K Robinson	9
8	Treatment of ulcerative colitis with an engineered human anti‐TNFα antibody CDP571 1997 ·Alimentary Pharmacology & Therapeutics ·R.C. Evans, Lane L. Clarke, Patricia K. Heath, Sue Stephens, A I Morris, J. M. Rhodes	101
9	CDP571, a humanized antibody to human tumor necrosis factor-alpha 1995 ·Critical Care Medicine ·Jean-François Dhainaut, Jean‐Louis Vincent, Christian Richard, Philippe Lejeune, Claude Martin, Lisiane Fierobe, Sue Stephens, Ursula M. Ney, Mark Sopwith	96
10	Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock. 1994 ·The Journal of Experimental Medicine ·Amanda Suitters, Roly Foulkes, Steven M. Opal, Jean Palardy, J.S. Emtage, Mark W. Rolfe, Sue Stephens, (unknown), (unknown), L Chaplin	52
11	Monoclonal anti-TNF-α suppresses graft vs host disease reactions in an in vitro human skin model 1994 ·Cytokine ·Anne M. Dickinson, Lisbet Sviland, Graham Jackson, J Dunn, Sue Stephens, S.J. Proctor	4
12	Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis 1993 ·Critical Care Medicine ·Charles J. Fisher, Steven M. Opal, Jean-François Dhainaut, Sue Stephens, Janice L. Zimmerman, Peter Nightingale, (unknown), Roland M.H. Schein, Edward A. Panacek, Jean‐Louis Vincent, Garrett E. Foulke, Edward Warren, (unknown), Gilbert Park, Mark Bodmer, Jonathan Cohen, (unknown), Alan S. Cross, Jerald Sadoff	325
13	Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. 1993 ·The Journal of Immunology ·Lesley Probert, (unknown), Paola Corbella, (unknown), Evangelia Patsavoudi, Sue Stephens, (unknown), D Kioussis, George Kollias	75
14	Anti-TNF therapy inhibits fever in cerebral malaria 1993 ·QJM ·Dominic Kwiatkowski, M E Molyneux, Sue Stephens, Nigel Curtis, Nigel Klein, Pascal Pointaire, Marry R. Smit, R. Marshall Allan, David Brewster, Georges E. Grau, (unknown)	166
15	EVIDENCE THAT ANTIHUMAN TUMOR NECROSIS FACTOR MONOCLONAL ANTIBODY PREVENTS OKT3-INDUCED ACUTE SYNDROME 1992 ·Transplantation ·Bernard Charpentier, C Hiesse, Olivier Lantz, Christiane Ferran, Sue Stephens, (unknown), (unknown), (unknown), Jean‐François Bach, Lucienne Chatenoud	61
16	IN SITU EXPRESSION OF TUMOR NECROSIS FACTOR-ALPHA, INTERFERON-GAMMA, AND INTERLEUKIN-2 RECEPTORS IN RENAL ALLOGRAFT BIOPSIES 1992 ·Transplantation ·Irene L. Noronha, Maria Eberlein-Gonska, B. Hartley, Sue Stephens, J S Cameron, Rüdiger Waldherr	92
17	Tumour necrosis factor alpha in stool as a marker of intestinal inflammation breakdown → 1992 ·The Lancet ·Christian Braegger, Stephen J. Nicholls, Simon Murch, Thomas T. MacDonald, Sue Stephens	578
18	Monoclonal anti-tumor necrosis factor-α antibody treatment of rat cardiac allografts: Synergism with low-dose cyclosporine and immunohistological studies 1991 ·Journal of Surgical Research ·Philip Seu, David K. Imagawa, (unknown), Kim M. Olthoff, John Hart, Sue Stephens, Roy A. Dempsey, Ronald W. Busuttil	9
19	THE ROLE OF TUMOR NECROSIS FACTOR IN ALLOGRAFT REJECTION 1991 ·Transplantation ·David K. Imagawa, J. Michael Millis, Philip Seu, Kim M. Olthoff, John Hart, (unknown), Roy A. Dempsey, Sue Stephens, Ronald W. Busuttil	106
20	Monoclonal antibody to TN F in severe septic shock 1990 ·The Lancet ·Andrew Exley, J. Cohen, Wim A. Buurman, Robert L. Owen, (unknown), G C Hanson, (unknown), Mark Bodmer, Sue Stephens, Anna Riddell, Melissa J. Perry	150

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact